Search hospitals > New York > Bronx
Albert Einstein Comprehensive Cancer Center
Claim this profileBronx, New York 10461
Global Leader in Leukemia
Global Leader in Lymphoma
Conducts research for Breast Cancer
Conducts research for Brain Tumor
Conducts research for Solid Tumors
225 reported clinical trials
5 medical researchers
Summary
Albert Einstein Comprehensive Cancer Center is a medical facility located in Bronx, New York. This center is recognized for care of Leukemia, Lymphoma, Breast Cancer, Brain Tumor, Solid Tumors and other specialties. Albert Einstein Comprehensive Cancer Center is involved with conducting 225 clinical trials across 154 conditions. There are 5 research doctors associated with this hospital, such as Sanjay Goel, Ioannis Mantzaris, MD, Beth N. Mclellan, MD, and Anna Ferrari, MD.Area of expertise
1Leukemia
Global Leader2Lymphoma
Global LeaderStage IV
ARID1A positive
Stage III
Top PIs
Sanjay GoelMontefiore Medical Center4 years of reported clinical research
Expert in Solid Tumors
Expert in Tumors
22 reported clinical trials
31 drugs studied
Ioannis Mantzaris, MDMontefiore Medical Center - Moses Campus1 year of reported clinical research
Studies Leukemia
Studies Acute Myeloid Leukemia
7 reported clinical trials
19 drugs studied
Beth N. Mclellan, MDMontefiore Einstein Center for Cancer Care4 years of reported clinical research
Studies Hand-Foot Syndrome
1 reported clinical trial
2 drugs studied
Anna Ferrari, MDMontefiore Einstein Center for Cancer Care4 years of reported clinical research
Studies Prostate Cancer
1 reported clinical trial
3 drugs studied
Clinical Trials running at Albert Einstein Comprehensive Cancer Center
Solid Tumors
Tumors
Small Cell Lung Cancer
Lymphoma
Endometrial Cancer
Mesothelioma
Prostate Cancer
Cancer
Squamous Cell Carcinoma
Acute Myeloid Leukemia
SHR-A1811
for Solid Tumors
This trial is testing a new drug called SHR-A1811 to see if it is safe and effective for patients with advanced cancers that have the HER2 gene. The drug works by targeting and attacking these specific cancer cells.
Recruiting1 award Phase 15 criteria
DF1001
for Solid Cancers
This trial is testing a new treatment called DF1001-001 that helps the immune system target and destroy cancer cells. It focuses on patients with certain types of cancers that have a protein called HER2. The treatment works by activating immune cells to recognize and attack these cancer cells.
Recruiting1 award Phase 1 & 252 criteria
CPI-0209
for Cancer and Lymphoma
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209 is a small molecule inhibitor of EZH2.
Recruiting1 award Phase 1 & 28 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Albert Einstein Comprehensive Cancer Center?
Albert Einstein Comprehensive Cancer Center is a medical facility located in Bronx, New York. This center is recognized for care of Leukemia, Lymphoma, Breast Cancer, Brain Tumor, Solid Tumors and other specialties. Albert Einstein Comprehensive Cancer Center is involved with conducting 225 clinical trials across 154 conditions. There are 5 research doctors associated with this hospital, such as Sanjay Goel, Ioannis Mantzaris, MD, Beth N. Mclellan, MD, and Anna Ferrari, MD.